

Premium Cannabis Product Brand Recognized in Four Categories in Arizona’s Largest Cannabis Awards Program PHOENIX, Nov. 3, 2022 /PRNewswire/ — Item 9 Labs—the award-winning, premium cannabis brand from Item 9 Labs Corp. (OTCQX: INLB)—has officially earned more than 30 podium finishes at Arizona marijuana competitions for product excellence across their high-quality cannabis flower, pre-roll, concentrate and vape products. […]...

Item 9 Labs Corp. (OTCQX:INLB) Q3 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Jason Assad - Investor Relations Andrew Bowden - Chief Executive Officer Bobby Mikkelsen - Chief Financial Officer Jason Assad [Abrupt Start] Joining me on today's call is our Chief Executive Officer, Andrew Bowden and our Chief Financial Officer, Bobby Mikkelson. Shortly before this call, we filed our Form 10-Q, a copy of which is available on the company's website at item9labscorp.com.

Item 9 Labs Corp. (INLB) delivered earnings and revenue surprises of -100% and 29.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PHOENIX , Aug. 3, 2022 /PRNewswire/ -- Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—announced today that it will host a conference call on Tuesday August 16, 2022, to share financial results for the third quarter of fiscal year 2022, which ended June 30, 2022. The 10Q will be filed on Monday, August 15, 2022.

Item 9 Labs Corp. (OTCQX:INLB) Q2 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Jason Assad - Investor Relations Andrew Bowden - Chief Executive Officer Bobby Mikkelsen - Chief Financial Officer Conference Call Participants Jason Assad Hello, this is Jason Assad, Investor Relations with Item 9 Labs. Good afternoon, and welcome to Item 9 Labs Fiscal Q2 2022 Results Conference Call for the three months ended March 31, 2022.

Item 9 Labs Corp. (INLB) delivered earnings and revenue surprises of -33.33% and 9.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Vertically Integrated Cannabis Dispensary Franchisor and Operator to Share Recent Positive Momentum for Accelerated National Growth in 2022 PHOENIX , April 5, 2022 /PRNewswire/ -- Item 9 Labs Corp. (OTCQX: INLB) (the "Company") – a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products – announced today that the Company's executive team will be participating in multiple investor events in April. These events include: Noble Capital Markets' 18th Annual Small & Microcap Investor Conference (NobleCon18), Sequire's Cannabis & Psychedelic Virtual Conference and Benzinga's Spring Cannabis Capital Conference.

PHOENIX, Feb. 21, 2022 /PRNewswire/ -- Unity Rd., the first true vertically integrated cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), continues to establish itself as a rising trailblazer in franchising.
No recent filings indexed.